Cell-free DNA clinical trials at University of California Health
2 research studies open to eligible people
Blood Collection Study in a Kidney Transplant Population
open to eligible people ages 18 years and up
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.
at UCSF
Non-invasive Prediction of EArly Cardiac rEjection
open to eligible people ages 6-25
Acute rejection remains a major cause of morbidity and mortality in pediatric patients after heart transplant. In order to screen for rejection, most centers perform heart catheterizations with endomyocardial biopsies frequently in the first year post transplant and then every 1-2 years thereafter; these biopsies are associated with complications, can cause significant anxiety in patients and family members, and are a significant cost for the healthcare system. This project will evaluate non-invasive methods of detecting rejection using cardiac magnetic resonance imaging and blood testing with a goal to reduce the required number of cardiac catheterizations.
at UCLA
Our lead scientists for Cell-free DNA research studies include Amarpali Brar, MD.
Last updated: